IPT 002
Alternative Names: IPT-002Latest Information Update: 28 Jun 2024
At a glance
- Originator INTELLiSTEM Technologies
- Class Peptide vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ebola virus infections
Most Recent Events
- 28 Jun 2024 No recent reports of development identified for preclinical development in Ebola-virus-infections in Canada (Parenteral)
- 28 Jun 2024 No recent reports of development identified for preclinical development in Ebola-virus-infections(Prevention) in Canada (Parenteral)
- 05 May 2020 Preclinical trials in Ebola virus infections (Prevention) in Canada (Parenteral), prior to May 2020 (INTELLiSTEM Technologies pipeline, May 2020)